Application of Humanized Zebrafish Model in the Suppression of SARS-CoV-2 Spike Protein Induced Pathology by Tri-Herbal Medicine Coronil Via Cytokine Modulation

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2020 Nov 5

PMID 33147850

Citations 22

Authors

Acharya Balkrishna

Siva Kumar Solleti

Sudeep Verma

Anurag Varshney

Affiliations

Soon will be listed here.

Abstract

Zebrafish has been a reliable model system for studying human viral pathologies. SARS-CoV-2 viral infection has become a global chaos, affecting millions of people. There is an urgent need to contain the pandemic and develop reliable therapies. We report the use of a humanized zebrafish model, xeno-transplanted with human lung epithelial cells, A549, for studying the protective effects of a tri-herbal medicine Coronil. At human relevant doses of 12 and 58 µg/kg, Coronil inhibited SARS-CoV-2 spike protein, induced humanized zebrafish mortality, and rescued from behavioral fever. Morphological and cellular abnormalities along with granulocyte and macrophage accumulation in the swim bladder were restored to normal. Skin hemorrhage, renal cell degeneration, and necrosis were also significantly attenuated by Coronil treatment. Ultra-high-performance liquid chromatography (UHPLC) analysis identified ursolic acid, betulinic acid, withanone, withaferine A, withanoside IV-V, cordifolioside A, magnoflorine, rosmarinic acid, and palmatine as phyto-metabolites present in Coronil. In A549 cells, Coronil attenuated the IL-1β induced IL-6 and TNF-α cytokine secretions, and decreased TNF-α induced NF-κB/AP-1 transcriptional activity. Taken together, we show the disease modifying immunomodulatory properties of Coronil, at human equivalent doses, in rescuing the pathological features induced by the SARS-CoV-2 spike protein, suggesting its potential use in SARS-CoV-2 infectivity.

Citing Articles

Zebrafish as a model organism for virus disease research: Current status and future directions.

Fajar S, Dwi S, Nur I, Wahyu A, Sukamto S M, Winda A Heliyon. 2024; 10(13):e33865.

PMID: 39071624 PMC: 11282986. DOI: 10.1016/j.heliyon.2024.e33865.

Ontology-based taxonomical analysis of experimentally verified natural and laboratory human coronavirus hosts and its implication for COVID-19 virus origination and transmission.

Wang Y, Ye M, Zhang F, Freeman Z, Yu H, Ye X PLoS One. 2024; 19(1):e0295541.

PMID: 38252647 PMC: 10802970. DOI: 10.1371/journal.pone.0295541.

A study on the effect of natural products against the transmission of B.1.1.529 Omicron.

Sami Alkafaas S, Abdallah A, Hussien A, Bedair H, Abdo M, Ghosh S Virol J. 2023; 20(1):191.

PMID: 37626376 PMC: 10464336. DOI: 10.1186/s12985-023-02160-6.

A novel insight on SARS-CoV-2 S-derived fragments in the control of the host immunity.

Bastos T, de Paula A, Dos Santos Luz R, Garnique A, Belo M, Eto S Sci Rep. 2023; 13(1):8060.

PMID: 37198208 PMC: 10191404. DOI: 10.1038/s41598-023-29588-8.

Photobiomodulation Reduces the Cytokine Storm Syndrome Associated with COVID-19 in the Zebrafish Model.

Rosa I, Pecanha A, Carvalho T, Alexandre L, Ferreira V, Doretto L Int J Mol Sci. 2023; 24(7).

PMID: 37047078 PMC: 10094635. DOI: 10.3390/ijms24076104.

References

Kumar V, Dhanjal J, Kaul S, Wadhwa R, Sundar D . Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (M) of SARS-CoV-2 and inhibit its activity. J Biomol Struct Dyn. 2020; 39(11):3842-3854. PMC: 7284143. DOI: 10.1080/07391102.2020.1772108. View

Cohen M . Tulsi - Ocimum sanctum: A herb for all reasons. J Ayurveda Integr Med. 2015; 5(4):251-9. PMC: 4296439. DOI: 10.4103/0975-9476.146554. View

Panchabhai T, Kulkarni U, Rege N . Validation of therapeutic claims of Tinospora cordifolia: a review. Phytother Res. 2008; 22(4):425-41. DOI: 10.1002/ptr.2347. View

Pattanayak P, Behera P, Das D, Panda S . Ocimum sanctum Linn. A reservoir plant for therapeutic applications: An overview. Pharmacogn Rev. 2012; 4(7):95-105. PMC: 3249909. DOI: 10.4103/0973-7847.65323. View

Barnes P . Transcription factors in airway diseases. Lab Invest. 2006; 86(9):867-72. DOI: 10.1038/labinvest.3700456. View

Ducharme N, Reif D, Gustafsson J, Bondesson M . Comparison of toxicity values across zebrafish early life stages and mammalian studies: Implications for chemical testing. Reprod Toxicol. 2014; 55:3-10. PMC: 5396953. DOI: 10.1016/j.reprotox.2014.09.005. View

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

Takayama K . In Vitro and Animal Models for SARS-CoV-2 research. Trends Pharmacol Sci. 2020; 41(8):513-517. PMC: 7260555. DOI: 10.1016/j.tips.2020.05.005. View

Tohme M, Gimenez M, Peralta A, Colombo M, Delgui L . Ursolic acid: A novel antiviral compound inhibiting rotavirus infection in vitro. Int J Antimicrob Agents. 2019; 54(5):601-609. DOI: 10.1016/j.ijantimicag.2019.07.015. View

10.

Gomes M, Mostowy S . The Case for Modeling Human Infection in Zebrafish. Trends Microbiol. 2019; 28(1):10-18. DOI: 10.1016/j.tim.2019.08.005. View

11.

Yao D, Li H, Gou Y, Zhang H, Vlessidis A, Zhou H . Betulinic acid-mediated inhibitory effect on hepatitis B virus by suppression of manganese superoxide dismutase expression. FEBS J. 2009; 276(9):2599-614. DOI: 10.1111/j.1742-4658.2009.06988.x. View

12.

Miller M, Cho J, Pham A, Ramsdell J, Broide D . Adiponectin and functional adiponectin receptor 1 are expressed by airway epithelial cells in chronic obstructive pulmonary disease. J Immunol. 2008; 182(1):684-91. DOI: 10.4049/jimmunol.182.1.684. View

13.

Chikhale R, Gurav S, Patil R, Sinha S, Prasad S, Shakya A . Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an approach. J Biomol Struct Dyn. 2020; 39(12):4510-4521. PMC: 7332873. DOI: 10.1080/07391102.2020.1778539. View

14.

CARSWELL E, Old L, Kassel R, Green S, Fiore N, Williamson B . An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975; 72(9):3666-70. PMC: 433057. DOI: 10.1073/pnas.72.9.3666. View

15.

Varela M, Figueras A, Novoa B . Modelling viral infections using zebrafish: Innate immune response and antiviral research. Antiviral Res. 2016; 139:59-68. DOI: 10.1016/j.antiviral.2016.12.013. View

16.

Runfeng L, Yunlong H, Jicheng H, Weiqi P, Qinhai M, Yongxia S . Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacol Res. 2020; 156:104761. PMC: 7102548. DOI: 10.1016/j.phrs.2020.104761. View

17.

Tsui P, Kwok M, Yuen H, Lai S . Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis. 2003; 9(9):1064-9. PMC: 3016795. DOI: 10.3201/eid0909.030362. View

18.

Kuba K, Imai Y, Penninger J . Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol. 2006; 6(3):271-6. PMC: 7106490. DOI: 10.1016/j.coph.2006.03.001. View

19.

Walls A, Park Y, Tortorici M, Wall A, McGuire A, Veesler D . Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020; 181(2):281-292.e6. PMC: 7102599. DOI: 10.1016/j.cell.2020.02.058. View

20.

Zaki A, van Boheemen S, Bestebroer T, Osterhaus A, Fouchier R . Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012; 367(19):1814-20. DOI: 10.1056/NEJMoa1211721. View